135 related articles for article (PubMed ID: 11674924)
21. Sera from patients with multiple drug allergy syndrome contain circulating histamine-releasing factors.
Asero R; Tedeschi A; Lorini M; Caldironi G; Barocci F
Int Arch Allergy Immunol; 2003 Jul; 131(3):195-200. PubMed ID: 12876410
[TBL] [Abstract][Full Text] [Related]
22. Activated status of basophils in chronic urticaria leads to interleukin-3 hyper-responsiveness and enhancement of histamine release induced by anti-IgE stimulus.
Lourenço FD; Azor MH; Santos JC; Prearo E; Maruta CW; Rivitti EA; Duarte AJ; Sato MN
Br J Dermatol; 2008 May; 158(5):979-86. PubMed ID: 18341658
[TBL] [Abstract][Full Text] [Related]
23. Evidence of in vivo basophil activation in chronic idiopathic urticaria.
Vasagar K; Vonakis BM; Gober LM; Viksman A; Gibbons SP; Saini SS
Clin Exp Allergy; 2006 Jun; 36(6):770-6. PubMed ID: 16776678
[TBL] [Abstract][Full Text] [Related]
24. Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs.
Zembowicz A; Mastalerz L; Setkowicz M; Radziszewski W; Szczeklik A
Arch Dermatol; 2003 Dec; 139(12):1577-82. PubMed ID: 14676074
[TBL] [Abstract][Full Text] [Related]
25. IL3 effect on basophils histamine release upon stimulation with chronic urticaria sera.
Ferrer M; Luquin E; Kaplan AP
Allergy; 2003 Aug; 58(8):802-7. PubMed ID: 12859562
[TBL] [Abstract][Full Text] [Related]
26. Detection of basophil-activating IgG autoantibodies in chronic idiopathic urticaria by induction of CD 63.
De Swerdt A; Van Den Keybus C; Kasran A; Cadot P; Neyens K; Coorevits L; Kochuyt AM; Degreef H; Ceuppens JL
J Allergy Clin Immunol; 2005 Sep; 116(3):662-7. PubMed ID: 16159640
[TBL] [Abstract][Full Text] [Related]
27. Chronic Idiopathic Urticaria: Systemic Complaints and Their Relationship with Disease and Immune Measures.
Doong JC; Chichester K; Oliver ET; Schwartz LB; Saini SS
J Allergy Clin Immunol Pract; 2017; 5(5):1314-1318. PubMed ID: 28302451
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the in vivo autologous skin test with in vitro diagnostic tests for diagnosis of chronic autoimmune urticaria.
Altrich ML; Halsey JF; Altman LC
Allergy Asthma Proc; 2009; 30(1):28-34. PubMed ID: 19026096
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of autoimmune activation of basophils in chronic urticaria.
Kikuchi Y; Kaplan AP
J Allergy Clin Immunol; 2001 Jun; 107(6):1056-62. PubMed ID: 11398085
[TBL] [Abstract][Full Text] [Related]
30. Predictive value of autologous plasma skin test for multiple nonsteroidal anti-inflammatory drug intolerance.
Asero R
Int Arch Allergy Immunol; 2007; 144(3):226-30. PubMed ID: 17579281
[TBL] [Abstract][Full Text] [Related]
31. Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria.
Niimi N; Francis DM; Kermani F; O'Donnell BF; Hide M; Kobza-Black A; Winkelmann RK; Greaves MW; Barr RM
J Invest Dermatol; 1996 May; 106(5):1001-6. PubMed ID: 8618029
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for acetaminophen and nimesulide intolerance in patients with NSAID-induced skin disorders.
Asero R
Ann Allergy Asthma Immunol; 1999 Jun; 82(6):554-8. PubMed ID: 10400483
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory effect of heparin on skin reactivity to autologous serum in chronic idiopathic urticaria.
Fagiolo U; Cancian M; Bertollo L; Peserico A; Amadori A
J Allergy Clin Immunol; 1999 Jun; 103(6):1143-7. PubMed ID: 10359897
[TBL] [Abstract][Full Text] [Related]
34. Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity.
Grattan CE; Dawn G; Gibbs S; Francis DM
Clin Exp Allergy; 2003 Mar; 33(3):337-41. PubMed ID: 12614448
[TBL] [Abstract][Full Text] [Related]
35. Circulating stem cell factor in patients with chronic idiopathic urticaria.
Asero R; Tedeschi A; Lorini M; Gerosa M; Meroni P; Riboldi P
Ann Allergy Asthma Immunol; 2003 Jul; 91(1):79-81. PubMed ID: 12877454
[TBL] [Abstract][Full Text] [Related]
36. Multiple nonsteroidal anti-inflammatory drug-induced cutaneous disease: what differentiates patients with and without underlying chronic spontaneous urticaria?
Asero R
Int Arch Allergy Immunol; 2014; 163(2):114-8. PubMed ID: 24335235
[TBL] [Abstract][Full Text] [Related]
37. Effect of stress on basophil function in chronic idiopathic urticaria.
Dyke SM; Carey BS; Kaminski ER
Clin Exp Allergy; 2008 Jan; 38(1):86-92. PubMed ID: 17976217
[TBL] [Abstract][Full Text] [Related]
38. Non-steroidal anti-inflammatory drug hypersensitivity in adults and the factors associated with asthma.
Karakaya G; Celebioglu E; Kalyoncu AF
Respir Med; 2013 Jul; 107(7):967-74. PubMed ID: 23643317
[TBL] [Abstract][Full Text] [Related]
39. Basophil phenotypes in chronic idiopathic urticaria in relation to disease activity and autoantibodies.
Eckman JA; Hamilton RG; Gober LM; Sterba PM; Saini SS
J Invest Dermatol; 2008 Aug; 128(8):1956-63. PubMed ID: 18356810
[TBL] [Abstract][Full Text] [Related]
40. Validation of basophil histamine release against the autologous serum skin test and outcome of serum-induced basophil histamine release studies in a large population of chronic urticaria patients.
Platzer MH; Grattan CE; Poulsen LK; Skov PS
Allergy; 2005 Sep; 60(9):1152-6. PubMed ID: 16076300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
